South Korea

Pharmicell Co.,Ltd.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Chemical Manufacturing Available in: English Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

874, Eonju-ro Gangnam-gu Seoul
Seoul; Seoul; Map
Postal Code: 135811

Tel: 02-3496-
Fax: 02-3496-

Company Description
Pharmicell Co.,Ltd. is engaged in manufacturing biopharmaceutical medicines used in curing diseases including cancer, brain, heart diseases and nervous system disorder. The company operates in four business divisions: Stem Cell area is engaged in manufacturing cell therapeutics and stem cell therapeutics ; Bio-based area is engaged in conducting stem cell research; Chemical area is engaged in manufacturing nucleosides, mPEGs, flame retardants, intermediates including TPC, BPDO, IDB-BPD, Carbapenem intermediates, among others; and Cosmetics area is engaged in manufacturing beauty products including counter aging solution, counter aging cream, toner, eye-cream, emulsions, and others. Pharmicell Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1968 formerly known as FCB Twelve Co., Ltd.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details
Key Financial Highlights
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

What this report allows you to do

EMIS company reports provide the data you need to make accurate assessments about businesses you are interested in.

Identify sales opportunities

  • Does the company match your target demographic?
  • Who are the key executives?

Conduct risk assessment

  • Is the company creditworthy?
  • Is it financially stable?

Carry out strategic research

  • Is the company a potential business partner/investment opportunity?
  • What is its financial performance?

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.


company profiles

We have information on both public and private companies across 125 countries.



EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Contact us to learn more about our business solutions.
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.